何时、何种情况以及如何换药：骨髓纤维化中JAK抑制剂的应用指南
When, which and how to switch: Navigating JAK inhibitors in myelofibrosis.
作者信息
O'Sullivan Jennifer, Omerdeen Imran, Psaila Bethan
机构信息
MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
出版信息
Br J Haematol. 2024 Nov 27. doi: 10.1111/bjh.19929.
Abstract
Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi-naïve and for those who have previously been treated with a JAKi.
摘要
为初治的骨髓纤维化患者以及既往接受过JAK抑制剂（JAKi）治疗的患者选择JAKi治疗方案。
Zotero 插件